Compound Formulation definition

Compound Formulation means any specific combination of excipient(s) and the Active Ingredient developed as a result of the work conducted under this Agreement. CARDAX may use and disclose CAPSUGEL’s internal technical protocols and Background IP, to the extent necessary for Regulatory Approvals as contemplated by Section 2.3(b) to the extent reasonably determined by CAPSUGEL after notice and consultation with CAPSUGEL by CARDAX.
View Source

Examples of Compound Formulation in a sentence

  • CARDAX may use the confidential information of CAPSUGEL generated under this Agreement, except for CAPSUGEL’s internal technical protocols and Background IP, to the extent necessary (i) in connection with seeking regulatory approval for a Compound Formulation or the Product and/or (ii) filing a patent application.

  • In the event that CAPSUGEL reasonably determines that the development of the Compound Formulation is not feasible with Commercially Reasonable Efforts in accordance with the Development Plan, with such changes as reasonably requested by CAPSUGEL, then CAPSUGEL may discontinue the development of the Compound Formulation and Product and terminate this Agreement, in which case, CARDAX shall have the right to license the Intellectual Property Rights as provided in Section 4.

  • The Parties will jointly own all inventions and other Intellectual Property Rights jointly made under this Agreement that are directly resulting from work conducted under this Agreement in accordance with the Development Plan and related specifically to the Product or the Compound Formulation, including any patents, patent applications and other Intellectual Property Rights related to such inventions, if any, unless otherwise expressly set forth herein.

  • Should any Third Party infringe, or reasonably appear to be infringing, any Novacea Background Patents which adversely affect or could reasonably be expected to adversely affect the Development, Manufacture, use or Commercialization of Compound, Formulation or Licensed Product in the Field in the Territory, the Party learning of such infringement or potential infringement shall promptly notify the other upon learning of the same.

  • Each Party shall immediately give written notice to the other Party of any certification of which they become aware filed pursuant to 21 U.S.C. Section 355(b)(2)(A) (or any amendment or successor statute thereto) claiming that any Novacea Background Patents covering Compound, Formulation or Licensed Product are invalid or unenforceable, or that infringement will not arise from the Manufacture, use or sale of a product by a Third Party.

  • Compound, Formulation or Product, Genentech shall have the right to defend and control the defense of such claim, suit or other proceeding as well as to initiate and control any counterclaim or other similar action.

  • PFIZER shall be responsible for the manufacture of all commercial supplies of each PFIZER Compound, Formulation and each Licensed Product.

  • MAP, at its sole expense, shall control the defense and/or settlement of any Third Party Patent Claim, including without limitation, any Third Party Patent Claim that alleges or asserts that the development, processing, manufacture, use, import, export, offer for sale, or sale of the Particulate Formation of Compound, Formulation, a Device and/or the Product, in each case infringes a Third Party Patent.